Nature Communications (Nov 2017)

Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment

  • Yanyun Gu,
  • Xiaokai Wang,
  • Junhua Li,
  • Yifei Zhang,
  • Huanzi Zhong,
  • Ruixin Liu,
  • Dongya Zhang,
  • Qiang Feng,
  • Xiaoyan Xie,
  • Jie Hong,
  • Huahui Ren,
  • Wei Liu,
  • Jing Ma,
  • Qing Su,
  • Hongmei Zhang,
  • Jialin Yang,
  • Xiaoling Wang,
  • Xinjie Zhao,
  • Weiqiong Gu,
  • Yufang Bi,
  • Yongde Peng,
  • Xiaoqiang Xu,
  • Huihua Xia,
  • Fang Li,
  • Xun Xu,
  • Huanming Yang,
  • Guowang Xu,
  • Lise Madsen,
  • Karsten Kristiansen,
  • Guang Ning,
  • Weiqing Wang

DOI
https://doi.org/10.1038/s41467-017-01682-2
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 12

Abstract

Read online

The authors examine the effects of antidiabetic medication on the gut microbiome and bile acid composition and show that these data can be used to stratify treatment regimens for type 2 diabetes.